Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 1/20 | 0.31 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | PIM1 | P11309 | 1/20 | 0.31 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.31 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.31 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.31 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CDC14B | O60729 | 1/20 | 0.30 |
| ▸ | CDC14A | Q9UNH5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26313057 | 0.89 | PSMB5 (0.34) | CYP1A2CDC14BCDC14A | |
| SCHEMBL24256087 | 0.89 | PSMB5 (0.34) | CYP1A2CDC14BCDC14A | |
| SCHEMBL26415506 | 0.87 | L3MBTL1 (0.32) | PLA2G2APLA2G4A | |
| SCHEMBL26313082 | 0.85 | CDC14B (0.33) | CYP1A2CDC14BCDC14A | |
| SCHEMBL24256957 | 0.85 | CDC14B (0.35) | CYP1A2CDC14BCDC14A | |
| SCHEMBL24255539 | 0.85 | CDC14B (0.35) | CYP1A2CDC14BCDC14A | |
| SCHEMBL26415666 | 0.85 | L3MBTL1 (0.33) | CYP1A2 | |
| SCHEMBL26415510 | 0.82 | L3MBTL1 (0.33) | — | |
| SCHEMBL26313076 | 0.82 | KDM4E (0.32) | CYP1A2CDC14BCDC14A | |
| SCHEMBL26313075 | 0.82 | PSMB5 (0.33) | CYP1A2CDC14BCDC14A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230128360-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE | LT MATERIALS CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230128360-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE | CRY1, ORC3, ODC1 | PLA2G2A 4034/4885PLA2G4A 3896/4885ALOX5 370/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.